Nucletron releases update for Oncentra Treatment Planning; FDA OKs Simulix Evolution

Nucletron B.V. has announced the clinical release of Oncentra Treatment Planning version 1.3.

Oncentra Treatment Planning is a PC-based planning system that features art image contouring, registration, fusion tools, dose calculation functionality and DICOM connectivity. The latest release offers archiving capabilities to any DICOM Archive supporting DICOM RT objects.

Nucletron also has received FDA 510(k) clearance for Simulix Evolution, an advanced digital technology for radiation treatment planning, simulation and verification that improves the quality of radiation cancer therapy

Simulix is available as a complete system, as well as an upgrade for existing Simulix systems. Simulix Evolution has undergone successful clinical testing in Europe and the United States.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.